Predicate |
Object |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02 |
filingDate |
2014-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2018-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-105214075-B |
titleOfInvention |
Regulate and control the novel drugs target spot of inflammatory factor or chemotactic factor (CF) generation |
abstract |
The present invention relates to the novel drugs target spot that regulation and control inflammatory factor or chemotactic factor (CF) produce.It is closely related that generation or the development of histone methylase Suv4 20h2 and inflammatory reaction are disclosed first, so that Suv4 20h2 can develop the medicine for adjusting inflammatory reaction as drug target. |
priorityDate |
2014-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |